Pay in 4 interest-free payments of $31.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
05% ophthalmic suspension in vernal keratoconjunctivitis
formation of phosphotyrosine residues in EGFR is not possible and the signal cascades are not initiated
Smiles: CN1CCN(CC1)S(=O)(=O)C1=CC(C2NC3=C(C(=O)N=2)N(C)N=C3CCC)=C(C=C1)OCC
LY2334737 is hydrolyzed by carboxylesterase 2 (CES2) and releases gemcitabine systemically over a period of time consistent with formation rate-limited kinetics
CAL-130 - CAS# 1431697-74-3 Catalog No.:M9912-10 05% ophthalmic suspension in vernalCAL 130 is a potent and selective PI3K gamma and delta inhibitor with potential anticancer activity. Constitutive phosphoinositide 3 kinase (PI3K) Akt activation is common in T cell acute lymphoblastic leukemia (T ALL). Although four distinct class I PI3K isoforms (, , , ) could participate in T ALL pathogenesis, none has been implicated in this process. In the absence of PTEN phosphatase tumor suppressor function, PI3K or PI3K alone can support
US$ 65.00
US$ 98.00
US$ 104.00
US$ 544.00